David Steinberg
Stock Analyst at Jefferies
(1.74)
# 1,890
Out of 4,479 analysts
17
Total ratings
57.14%
Success rate
17.35%
Average return
Main Sectors:
Top Industries:
8 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BHC Bausch Health Companies | Upgrades: Buy | $9 → $16 | $7.11 | +125.04% | 6 | Sep 20, 2023 | |
| PRGO Perrigo Company | Upgrades: Buy | n/a | $25.99 | - | 1 | Sep 30, 2021 | |
| SUPN Supernus Pharmaceuticals | Upgrades: Buy | n/a | $25.77 | - | 3 | Apr 13, 2021 | |
| JAZZ Jazz Pharmaceuticals | Maintains: Buy | n/a | $105.09 | - | 2 | Oct 9, 2020 | |
| OCUL Ocular Therapeutix | Initiates: Buy | n/a | $6.68 | - | 1 | Mar 17, 2020 | |
| SCPH scPharmaceuticals | Maintains: Buy | n/a | $4.21 | - | 2 | Jun 14, 2018 | |
| OPTN OptiNose | Initiates: Buy | n/a | $1.04 | - | 1 | Nov 7, 2017 | |
| SVRA Savara | Initiates: Buy | n/a | $4.30 | - | 1 | Sep 22, 2017 |
Bausch Health Companies
Sep 20, 2023
Upgrades: Buy
Price Target: $9 → $16
Current: $7.11
Upside: +125.04%
Perrigo Company
Sep 30, 2021
Upgrades: Buy
Price Target: n/a
Current: $25.99
Upside: -
Supernus Pharmaceuticals
Apr 13, 2021
Upgrades: Buy
Price Target: n/a
Current: $25.77
Upside: -
Jazz Pharmaceuticals
Oct 9, 2020
Maintains: Buy
Price Target: n/a
Current: $105.09
Upside: -
Ocular Therapeutix
Mar 17, 2020
Initiates: Buy
Price Target: n/a
Current: $6.68
Upside: -
scPharmaceuticals
Jun 14, 2018
Maintains: Buy
Price Target: n/a
Current: $4.21
Upside: -
OptiNose
Nov 7, 2017
Initiates: Buy
Price Target: n/a
Current: $1.04
Upside: -
Savara
Sep 22, 2017
Initiates: Buy
Price Target: n/a
Current: $4.30
Upside: -